Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.

Article  Google Scholar 

Brunner EJ, Shipley MJ, Britton AR, Stansfeld SA, Heuschmann PU, Rudd AG, Wolfe CD, Singh-Manoux A, Kivimaki M. Depressive disorder, coronary heart disease, and stroke: dose–response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol. 2014;21(3):340–6.

Article  PubMed  Google Scholar 

Reid S, Barbui C. Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ 2010; 340.

Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848–56.

Article  PubMed  Google Scholar 

Cipriani A, Brambilla P, Furukawa TA, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Reviews 2005;4.

Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108(1):2–8.

Article  PubMed  Google Scholar 

Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal A, Coupland C. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ. 2001;323(7314):666–9.

Article  PubMed  PubMed Central  Google Scholar 

Rosenberg LB, Whang W, Shimbo D, Shah A, Shapiro PA, Davidson KW. Exposure to tricyclic antidepressants is associated with an increased risk of incident CHD events in a population-based study. Int J Cardiol. 2010;145(1):124–5.

Article  PubMed  Google Scholar 

Tata L, West J, Smith C, Farrington P, Card T, Smeeth L, Hubbard R. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91(4):465–71.

Article  PubMed  PubMed Central  Google Scholar 

Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104(16):1894–8.

Article  PubMed  Google Scholar 

Scherrer JF, Garfield LD, Lustman PJ, Hauptman PJ, Chrusciel T, Zeringue A, Carney RM, Freedland KE, Bucholz KK, Owen R. Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med. 2011;124(4):318–24.

Article  PubMed  Google Scholar 

Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123–9.

Article  PubMed  Google Scholar 

Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108(1):32–6.

Article  PubMed  Google Scholar 

Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the nurses’ Health Study. J Am Coll Cardiol. 2009;53(11):950–8.

Article  PubMed  PubMed Central  Google Scholar 

Hamer M, Batty GD, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011;32(4):437–42.

Article  PubMed  Google Scholar 

Kimmel SE, Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol. 2011;72(3):514–7.

Article  PubMed  PubMed Central  Google Scholar 

Pizzi C, Rutjes AWS, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol. 2011;107(7):972–9.

Article  PubMed  Google Scholar 

Scabia G, Barone I, Mainardi M, Ceccarini G, Scali M, Buzzigoli E, Dattilo A, Vitti P, Gastaldelli A, Santini F. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF. Sci Rep. 2018;8(1):1781.

Article  PubMed  PubMed Central  Google Scholar 

Braz GRF, da Silva AI, Silva SCA, Pedroza AAS, de Lemos MDT, de Lima FAS, Silva TLA, Lagranha CJ. Chronic serotonin reuptake inhibition uncouples brown fat mitochondria and induces beiging/browning process of white fat in overfed rats. Life Sci. 2020;245:117307.

Article  PubMed  Google Scholar 

Kim HW, Shi H, Winkler MA, Lee R, Weintraub NL. Perivascular adipose tissue and vascular perturbation/atherosclerosis. Arterioscler Thromb Vasc Biol. 2020;40(11):2569–76.

Article  PubMed  PubMed Central  Google Scholar 

Roth CL, Molica F, Kwak BR. Browning of white adipose tissue as a therapeutic tool in the fight against atherosclerosis. Metabolites. 2021;11(5):319.

Article  PubMed  PubMed Central  Google Scholar 

Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Kao Yang Y-H. Lai EC-C: Taiwan’s national health insurance research database: past and future. Clin Epidemiol 2019:349–58.

Cheng CL, Kao YHY, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–42.

Article  PubMed  Google Scholar 

Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kuo KN, Wu M-S, Lin J-T. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906–13.

Article  PubMed  Google Scholar 

Gau CS, Chang IS, Lin Wu FL, Yu HT, Huang YW, Chi CL, Chien SY, Lin KM, Liu MY, Wang HP. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co‐medication in Taiwan. Pharmacoepidemiol Drug Saf. 2007;16(1):86–95.

Article  PubMed  Google Scholar 

Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA. 2016;316(17):1818–9.

Article  PubMed  Google Scholar 

Gill R, Schumacher M. A simple test of the proportional hazards assumption. Biometrika. 1987;74(2):289–300.

Article  Google Scholar 

Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev. 2008;28(2):288–306.

Article  PubMed  Google Scholar 

Donovan MH, Tecott LH. Serotonin and the regulation of mammalian energy balance. Front NeuroSci. 2013;7:36.

Article  PubMed  PubMed Central  Google Scholar 

Baldwin D, Rudge S. The role of serotonin in depression and anxiety. Int Clin Psychopharmacol. 1995;9:41–5.

Article  PubMed  Google Scholar 

Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017;17(1):1–28.

Google Scholar 

Chiu Y-J, Tu H-H, Kung M-L, Wu H-J, Chen Y-W. Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis. Biomed Pharmacother. 2021;141:111848.

Article  PubMed  Google Scholar 

Berbée JF, Boon MR, Khedoe PPS, Bartelt A, Schlein C, Worthmann A, Kooijman S, Hoeke G, Mol IM, John C. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun. 2015;6(1):6356.

Article  PubMed  Google Scholar 

Ying Z, Tramper N, Zhou E, Boon MR, Rensen PC, Kooijman S. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans. Cardiovascular Res. 2023;119(4):905–18.

Article  Google Scholar 

Da Silva A, Braz G, Pedroza A, Nascimento L, Freitas C, Ferreira D, Manhães de Castro R, Lagranha C. Fluoxetine induces lean phenotype in rat by increasing the brown/white adipose tissue ratio and UCP1 expression. J Bioenerg Biomembr. 2015;47:309–18.

Article  PubMed  Google Scholar 

Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010;2010(1):289645.

Google Scholar 

Caiaffo V, Oliveira BD, de Sá FB, Evêncio Neto J. Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine. Pharmacol Res Perspect. 2016;4(3):e00231.

Article  PubMed